127 related articles for article (PubMed ID: 10384064)
1. Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease.
Iversen ET; Sørensen T; Heckscher T; Jensen JI
Lung; 1999; 177(4):263-71. PubMed ID: 10384064
[TBL] [Abstract][Full Text] [Related]
2. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
3. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
4. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
Jaeschke R; Guyatt GH; Willan A; Cook D; Harper S; Morris J; Ramsdale H; Haddon R; Newhouse M
Thorax; 1994 May; 49(5):479-84. PubMed ID: 8016770
[TBL] [Abstract][Full Text] [Related]
5. Influence of a beta2-agonist on physical performance at low temperature in elite athletes.
Larsson K; Gavhed D; Larsson L; Holmér I; Jorfelt L; Ohlsén P
Med Sci Sports Exerc; 1997 Dec; 29(12):1631-6. PubMed ID: 9432097
[TBL] [Abstract][Full Text] [Related]
6. The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease.
Evald T; Keittelmann S; Sindrup JH; Lange P
Respir Med; 1992 Mar; 86(2):93-6. PubMed ID: 1615190
[TBL] [Abstract][Full Text] [Related]
7. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Mochizuki H; Nanjo Y; Takahashi H
Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
[TBL] [Abstract][Full Text] [Related]
8. Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease.
Maesen BL; Westermann CJ; Duurkens VA; van den Bosch JM
Eur Respir J; 1999 May; 13(5):1103-8. PubMed ID: 10414411
[TBL] [Abstract][Full Text] [Related]
9. Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
Simpson AJ; Tufvesson E; Anderson SD; Romer LM; Bjermer L; Kippelen P
J Appl Physiol (1985); 2013 Nov; 115(10):1450-6. PubMed ID: 24030662
[TBL] [Abstract][Full Text] [Related]
10. Terbutaline in COPD comparison between Turbuhaler and chlorofluorocarbon (CFC) inhaler.
Formgren H; Sjökvist A; Ståhl E; Wirén JE
Lung; 1994; 172(5):271-80. PubMed ID: 7934151
[TBL] [Abstract][Full Text] [Related]
11. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
[TBL] [Abstract][Full Text] [Related]
12. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease.
Lipworth BJ; Clark RA; Dhillon DP; McDevitt DG
Am Rev Respir Dis; 1990 Aug; 142(2):338-42. PubMed ID: 2166455
[TBL] [Abstract][Full Text] [Related]
14. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
[TBL] [Abstract][Full Text] [Related]
15. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
16. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma.
Ståhl E; Ribeiro LB; Sandahl G
Pediatr Pulmonol; 1996 Aug; 22(2):106-10. PubMed ID: 8875584
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation.
Crisafulli E; Scelfo C; Tzani P; Aiello M; Bertorelli G; Chetta A
Eur J Prev Cardiol; 2017 Jun; 24(9):990-999. PubMed ID: 28436723
[TBL] [Abstract][Full Text] [Related]
18. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
[TBL] [Abstract][Full Text] [Related]
19. The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients.
Rodríguez-Carballeira M; Heredia JL; Rué M; Quintana S; Gómez L
Pulm Pharmacol Ther; 2001; 14(1):61-5. PubMed ID: 11162421
[TBL] [Abstract][Full Text] [Related]
20. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
